نتایج جستجو برای: 52 high week

تعداد نتایج: 2230247  

2017
Satoshi Kuwabara Masahiro Mori Sonoko Misawa Miki Suzuki Kazutoshi Nishiyama Tatsuro Mutoh Shizuki Doi Norito Kokubun Mikiko Kamijo Hiroo Yoshikawa Koji Abe Yoshihiko Nishida Kazumasa Okada Kenji Sekiguchi Ko Sakamoto Susumu Kusunoki Gen Sobue Ryuji Kaji

OBJECTIVE Short-term efficacy of induction therapy with intravenous immunoglobulin (Ig) in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) is well established. However, data of previous studies on maintenance therapy were limited up to 24-week treatment period. We aimed to investigate the efficacy and safety of longer-term intravenous Ig therapy for 52 weeks. METHODS Th...

Journal: :Modern rheumatology 2007
Masako Hara Tohru Abe Sachiko Sugawara Yutaka Mizushima Keiko Hoshi Shoichiro Irimajiri Hiroshi Hashimoto Shinichi Yoshino Nobuo Matsui Masashi Nobunaga

We conducted a 52-week clinical study of iguratimod in 394 Japanese patients with rheumatoid arthritis to evaluate the long-term safety of the drug. Iguratimod was administered orally at a daily dose of 25 mg for the first 4 weeks and 50 mg for the subsequent 48 weeks. Some of the patients continued the treatment for 100 weeks for their benefit. The cumulative incidence of adverse events for 10...

Journal: :British journal of haematology 2012
Ifeyinwa Osunkwo Thomas R Ziegler Jessica Alvarez Courtney McCracken Korin Cherry Chinyere E Osunkwo Solomon F Ofori-Acquah Samit Ghosh Adeolu Ogunbobode Jim Rhodes James R Eckman Carlton Dampier Vin Tangpricha

We report results of a pilot study of high-dose vitamin D in sickle cell disease (SCD). Subjects were given a 6-week course of oral high-dose cholecalciferol (4000-100 000 IU per week) or placebo and monitored prospectively for a period of six months. Vitamin D insufficiency and deficiency was present at baseline in 82·5% and 52·5% of subjects, respectively. Subjects who received high-dose vita...

2008
H-J Aubin A Bobak J R Britton C Oncken C B Billing J Gong K E Williams K R Reeves

BACKGROUND Varenicline, a new treatment for smoking cessation, has demonstrated significantly greater efficacy over placebo and sustained release bupropion (bupropion SR). A study was undertaken to compare a 12-week standard regimen of varenicline with a 10-week standard regimen of transdermal nicotine replacement therapy (NRT) for smoking cessation. METHODS In this 52-week, open-label, rando...

2013
N Thalange A Bereket J Larsen L C Hiort V Peterkova

AIMS This 52-week, randomized, multinational, open-label, parallel-group, non-inferiority trial investigated the efficacy and safety of basal-bolus treatment with insulin detemir vs. NPH (neutral protamine Hagedorn) insulin, in combination with insulin aspart, in subjects aged 2-16 years with Type 1 diabetes mellitus. METHODS Of the 347 randomized and exposed subjects, 177 received insulin de...

2016
Satoshi Asakura Taiji Hayano Atsushi Hagino Tsukasa Koyama

PURPOSE To investigate the safety, tolerability, and effectiveness of escitalopram in patients with social anxiety disorder in Japan. METHODS A 52-week, open-label study was conducted in Japanese patients with social anxiety disorder with a total score ≥60 on the Liebowitz Social Anxiety Scale - Japanese Version (LSAS-J) and ≥4 on the Clinical Global Impression - Severity Scale. Escitalopram ...

Journal: :The Journal of rheumatology 2015
Arthur Kavanaugh Philip J Mease Juan J Gomez-Reino Adewale O Adebajo Jürgen Wollenhaupt Dafna D Gladman Marla Hochfeld Lichen L Teng Georg Schett Eric Lespessailles Stephen Hall

OBJECTIVE To evaluate the efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, over 52 weeks in patients with active psoriatic arthritis (PsA) despite prior treatment. METHODS Patients were randomized to placebo (n = 168), apremilast 20 mg BID (n = 168), or apremilast 30 mg BID (n = 168). Patients whose swollen and tender joint counts had not improved by ≥ 20% at Week 16 ...

Journal: :Arthritis and rheumatism 2008
Edward Keystone Désireé van der Heijde David Mason Robert Landewé Ronald Van Vollenhoven Bernard Combe Paul Emery Vibeke Strand Philip Mease Chintu Desai Karel Pavelka

OBJECTIVE To evaluate the efficacy and safety of 2 dosage regimens of lyophilized certolizumab pegol (a novel PEGylated anti-tumor necrosis factor agent) as adjunctive therapy to methotrexate (MTX) in patients with active rheumatoid arthritis (RA) with an inadequate response to MTX therapy alone. METHODS In this 52-week, phase III, multicenter, randomized, double-blind, placebo-controlled, pa...

Amir Nik-Azin, Mohammad Reza Naenian, Mohammad Reza Shairi,

Introduction: The purpose of the present study was to examine the validity and reliability of the Health Related Quality of Life Questionnaire (KIDSCREEN-52) in a sample of Iranian students. Materials and Method: Using Multistage Sampling, 551 students from middle and high school, studying in Yazd city were selected as a sample. In this study” KIDSCREEN-52 HRQOL questionnaire”, and some other ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید